Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

Provided By Globe Newswire

Last update: Feb 7, 2023

SANTA MONICA, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) announced today that the Committee on Foreign Investment in the United States (CFIUS) approved the previously announced Merger Agreement (the Agreement) for Opiant to be acquired by Indivior PLC (LSE: INDV).